Led · Series A · Jan 2020

Progentec is an Oklahoma City-based company developing next-generation diagnostics and digital therapeutics for the management of autoimmune diseases. The company combines clinically-validated diagnostic interventions with digital technologies to improve access and health outcomes for patients in areas with high unmet need. Its core work includes building a CLIA laboratory and digital platforms targeted at lupus management. Future plans funded by the round include research into digital biomarkers and enabling remote delivery of digital therapeutic programs. Led by CEO Mohan Purushothaman, Progentec will use the financing as go-to-market capital for its lab and digital products. The company recently closed a $5M Series A to advance these initiatives. Progentec Diagnostics develops biomarker-based diagnostic tests and platforms focused on lupus. Its core product suite includes tests to diagnose disease before symptoms, tools to monitor and predict disease activity levels, and a biomarker-based disease-activity index. Technology created by the Oklahoma Medical Research Foundation (OMRF) underpins the platform. The company plans to use proceeds from its second funding round to bring a flare-up identification tool and the disease-activity index closer to commercialization. Progentec recently acquired LupusCorner and intends to integrate that patient-empowerment platform and its data insights into a first-in-class lupus-management offering; the founders of LupusCorner have joined the team. Led by CEO Mohan Purushothaman and based in Oklahoma City, Progentec is advancing toward commercial launch.

Led · Seed · Apr 2019

Simergent is advancing Archimedes, an automated peritoneal dialysis system designed to expand access to home dialysis at an affordable price point with usability and safety features. The company plans to continue development for the US and international markets. It will use the recently raised funds to complete design, manufacturing and regulatory testing required for FDA clearance. Simergent is led by co-founder and CEO Steve Lindo. The company has offices in Oklahoma City, OK and Chicago, IL and is part of the MATTER healthtech incubator. Financially, it has just closed a seed round to support its next development and regulatory milestones.

Led · Series A · Oct 2018

Whiteboard Technologies develops Whiteboard Mortgage CRM, a web-based customer relationship management SaaS product tailored to the mortgage loan industry. The product is powered by The Mortgage Playbook and allows mortgage loan officers to follow up on new leads while keeping borrowers and partners updated throughout the loan process. It enables lenders to leverage proven business strategies across their enterprise and to maintain sales, marketing, and follow-up campaigns while ensuring company-wide compliance. Founded in 2015 by CEO Brian Bomar and based in Oklahoma City, the company targets mortgage lenders as its primary market. Whiteboard plans to use the new funding to grow aggressively within the mortgage industry and to identify additional vertical markets to pursue. The company completed a $2.5M Series A to support that expansion.

Led · Series A · Dec 2017

iRecommend Software develops a recommendation engine that leverages artificial intelligence, deep learning, and a proprietary algorithm to ingest big data from thousands of data feeds. The engine generates relevant, user-specific recommendations across retail, recruiting, real estate, entertainment, and healthcare industries. The company was founded in 2016 by John Morad and Mark Allen and is based in Tulsa, Okla. It plans to use the recent funding to expand global sales and marketing efforts and to complete a large online retail client integration. iRecommend also intends to commercialize SaaS subscription modules for the real estate and recruiting industries. The article reports the company closed a $1.85M Series A in December 2017.

Led · Series A · Dec 2017

Linear Health Sciences develops the Orchid Safety Release Valve (SRV) and other safety technologies for medical tubing intended to improve care for patients, caregivers and healthcare institutions. The company touts patient, nurse and hospital benefits such as fewer IV restarts, reduced need for invasive lines, greater nursing efficiency, and cost savings for hospitals. Management said the business is poised for a market launch in 2018. Linear has leveraged accelerator and grant programs including Medtech Innovator's Virtual Accelerator and the Global Center for Medical Innovation to guide product development and commercialization. The firm estimates the market for its technology at $1 billion annually. Linear was founded by a physician and two engineers and has used both private investments and accelerator support to advance product concept and development.